NCT06557044

The Analgesic Efficacy of Pericapsular Nerve Group (PENG) Block in Patients Undergoing Primary Total Hip Arthoplasty:

The Analgesic Efficacy of Pericapsular Nerve Group (PENG) Block in Patients Undergoing Primary Total Hip Arthoplasty: a Prospective, Double-blinded, Randomized Controlled Trial

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 110 (estimated)
• Sponsor: Diakonie-Klinikum Stuttgart · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The aim of this study is to investigate the analgesic efficacy of the pericapsular nerve group (PENG) block during the implantation of hip endoprostheses. The study is designed as a prospective randomized double-blind study and the study participants were randomized into 2 arms and either 20 ml ropivacaine 0.5% (verum group) or 20 ml physiological saline solution (placebo group) will be applied.

Conditions

• Prospective
• Randomized
• Double-blind

Interventions

Type	Name	Description
DRUG	Ropivacaine	PENG block with ropivacaine
OTHER	Physiological saline	Placebo control

Timeline

• Start date: 2024-03-07
• Primary completion: 2025-03-01
• Completion: 2025-03-01
• First posted: 2024-08-16
• Last updated: 2024-08-16

Locations

1 site across 1 country: Germany